Olympus AU Series Offers Benefits of Standardization Program
Chicago (AACC Annual Meeting) - The Diagnostic Systems Group of Olympus America Inc. today unveiled a new operating model that uses standardization to increase productivity and decrease operating costs for hospitals, core and commercial laboratories. The Olympus Standardization design is integrated throughout the product line of Olympus AU chemistry-immuno analyzers, the AU400TM, AU640TM, AU2700TM and AU5400TM systems. This standardization covers chemistry-immuno testing from
Olympus Unveils OLA4000TM Workcell Laboratory Automation System
Melville, NY - Olympus Diagnostic Systems Group debuted the new OLA4000TMlaboratory automation system during the AACC annual meeting in Chicago. The OLA4000 is an innovative new workcell laboratory automation solution designed for medium and high volume hospitals and commercial reference laboratories. The OLA4000 fully automates the labor-intensive tasks associated with specimen processing within the chemistry-immuno work area. It streamlines workflow and reduces costs associ
New Olympus Liquid Stable CK (NAC) Reagent with Extended Linearity and On-board Stability
Melville, NY (April 23, 2001) - The Diagnostic Systems Group of Olympus America Inc. has introduced its new Creatine Kinase (NAC) reagent, now available in small and large kit sizes. This new reagent is a ready-to-use liquid formulation with extended linearity to 2000 U/L and a 30-day on-board stability for Olympus's full-line of automated chemistry-immuno analyzers, including the AU400TM, AU600TM, AU640TM and AU1000TM, as well as the new AU2700TMsystem. An economical solutio
New Olympus Carbamazepine, Gentamicin Plus, Procainamide, Barbiturate, Ethanol, and Methadone Reagen
Melville, NY - The Diagnostic Systems Group of Olympus America Inc. has introduced new Therapeutic Drug Monitoring (TDM) and Drugs of Abuse (DAT) reagents. In ready-to-use liquid formulations, the new TDMs (Carbamazepine, Gentamicin Plus, and Procainamide) and DATs (Barbiturate, Ethanol, and Methadone) feature 90-day to 60-day on-board stability with 14-day calibration stability on Olympus' full line of automated chemistry-immuno analyzers, including the AU400TM, AU600TM, AU6
New Olympus Theophylline, Cocaine Metabolite, Methaqualone, PCP, Propoxyphene
Melville, NY - The Diagnostic Systems Group of Olympus America Inc. has introduced new Therapeutic Drug Monitoring (TDM) and Drugs of Abuse (DAT) reagents. In ready-to-use liquid formulations, the new TDM (Theophylline) and DATs (Cocaine Metabolite, Methaqualone, PCP, Propoxyphene) feature 90-day to 60-day on-board stability with 14-day calibration stability on Olympus' full line of automated chemistry-immuno analyzers, including the AU400TM, AU600TM, AU640TM, and AU2700TM sy
Olympus Develops High Sensitivity CRP Assay For Its Standardized AU-Series Analyzers
San Francisco, CA - Medical practitioners will soon be able to routinely order a new High Sensitivity C-Reactive Protein assay (CRP) now that Olympus Diagnostic Systems Group has designed the test for its standardized AU-Series of chemistry immuno systems. Olympus breakthrough technology allows laboratories to run the assay on their primary clinical chemistry analyzer without the need for a separate nephelometer or heterogeneous immunoassay analyzer. This has broad implicatio
Olympus Debuts High-Throughput AU5400TM Chemistry Immuno Analyzer
San Francisco, CA - Adding to its line of standardized chemistry immuno systems, Olympus Diagnostic Systems Group debuted the new high-volume AU5400TM* analyzer at AACC. Meeting the needs of high-volume commercial and hospital core laboratories, the Olympus AU5400 automates and consolidates chemistry-immuno testing with up to 147 on-board chemistries and performs up to 6,600 tests per hour. The AU5400 is designed to upgrade and replace Olympus AU5200 analyzers used in the maj
Olympus Signs Contract with U.S. Department of Veterans Affairs
Melville, NY - The Diagnostic Systems Group of Olympus America Inc. announced that it was awarded a contract for twenty chemistry immuno systems for the Veterans Integrated Service Network (VISN) 1 Consolidated Laboratory. The five-year contract provides for in-vitro diagnostics instruments, service and consumable products for its fourteen facilities in the New England states of Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, and Vermont. Awarded after a publi
Dade Behring and Olympus America Announce Enhanced U.S. Marketing and Distribution Relationship
San Francisco, CA - The Diagnostic Systems Group of Olympus America Inc. and Dade Behring Inc., manufacturer of Syva EMIT® drugs of abuse (DAT) and therapeutic drug monitoring (TDM) products, announced today that they have finalized terms on agreements that create U.S. sales, marketing and distribution relationships. The first agreement allows Dade Behring to sell Olympus analytical systems to the high-volume toxicology laboratories in the U.S. Dade Behring now can better mee
New Stable-Liquid Calcium Reagent from Olympus
Olympus America, Inc. has developed a new Calcium reagent for use on the Olympus AU400,™ AU600,™ AU640,™ and AU1000™ chemistry immuno systems. The new Calcium reagent uses an Arsenazo III formulation for enhanced performance and ease of use. The new Olympus Calcium reagent features extended 30-day, on-board and calibration stability. This liquid, ready-to-use reagent requires no preparation and comes in 500 and 1000 test cartridges to match the test volume requirements of any
